论文部分内容阅读
目的 Our previous study showed that lenvatinib upregulated programmed cell death 1ligand 1(PD-L1)in hepatoma cells,whereas regorafenib downregulated PD-L1,thecause of this discrepancy was unclear.This study aimed to elucidate the mechanismunderlying this phenomenon.